{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T01:08:15Z","timestamp":1780621695775,"version":"3.54.1"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,28]],"date-time":"2021-09-28T00:00:00Z","timestamp":1632787200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Methods & Clinical Development"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.omtm.2021.09.013","type":"journal-article","created":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T04:01:46Z","timestamp":1633060906000},"page":"307-318","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Biodistribution of intravitreal lenadogene nolparvovec gene therapy in nonhuman primates"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8475-9959","authenticated-orcid":false,"given":"David J.","family":"Calkins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7847-9320","authenticated-orcid":false,"given":"Patrick","family":"Yu-Wai-Man","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy J.","family":"Newman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1139-5178","authenticated-orcid":false,"given":"Magali","family":"Taiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4169-3937","authenticated-orcid":false,"given":"Pramila","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9mentine","family":"Chalmey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Rogue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerio","family":"Carelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0905-4745","authenticated-orcid":false,"given":"Philippe","family":"Ancian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 A.","family":"Sahel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2021.09.013_bib1","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0076-6879(96)64035-X","article-title":"Allotopic expression of mitochondrial ATP synthase genes in nucleus of Saccharomyces cerevisiae","volume":"264","author":"Gray","year":"1996","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.omtm.2021.09.013_bib2","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/ana.10354","article-title":"Rescue of a mitochondrial deficiency causing Leber Hereditary Optic Neuropathy","volume":"52","author":"Guy","year":"2002","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.omtm.2021.09.013_bib3","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1001\/archophthalmol.2010.135","article-title":"Induction of rapid and highly efficient expression of the human ND4 complex I subunit in the mouse visual system by self-complementary adeno-associated virus","volume":"128","author":"Koilkonda","year":"2010","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.omtm.2021.09.013_bib4","doi-asserted-by":"crossref","first-page":"7739","DOI":"10.1167\/iovs.14-15388","article-title":"LHON gene therapy vector prevents visual loss and optic neuropathy induced by G11778A mutant mitochondrial DNA: biodistribution and toxicology profile","volume":"55","author":"Koilkonda","year":"2014","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.omtm.2021.09.013_bib5","doi-asserted-by":"crossref","first-page":"15003","DOI":"10.1038\/mtm.2015.3","article-title":"Nuclear expression of mitochondrial ND4 leads to the protein assembling in complex I and prevents optic atrophy and visual loss","volume":"2","author":"Cwerman-Thibault","year":"2015","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2021.09.013_bib6","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1089\/rej.2006.0526","article-title":"Allotopic mRNA localization to the mitochondrial surface rescues respiratory chain defects in fibroblasts harboring mitochondrial DNA mutations affecting complex I or v subunits","volume":"10","author":"Bonnet","year":"2007","journal-title":"Rejuvenation Res."},{"key":"10.1016\/j.omtm.2021.09.013_bib7","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/j.bbamcr.2008.04.018","article-title":"The optimized allotopic expression of ND1 or ND4 genes restores respiratory chain complex I activity in fibroblasts harboring mutations in these genes","volume":"1783","author":"Bonnet","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.omtm.2021.09.013_bib8","doi-asserted-by":"crossref","first-page":"eaaz7423","DOI":"10.1126\/scitranslmed.aaz7423","article-title":"Bilateral visual improvement with unilateral gene therapy injection for Leber hereditary optic neuropathy","volume":"12","author":"Yu-Wai-Man","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtm.2021.09.013_bib9","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.ophtha.2020.12.012","article-title":"Efficacy and Safety of Intravitreal Gene Therapy for Leber Hereditary Optic Neuropathy Treated within 6 Months of Disease Onset","volume":"128","author":"Newman","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/j.omtm.2021.09.013_bib10","doi-asserted-by":"crossref","first-page":"662838","DOI":"10.3389\/fneur.2021.662838","article-title":"Intravitreal Gene Therapy vs. Natural History in Patients With Leber Hereditary Optic Neuropathy Carrying the m.11778G>A ND4 Mutation: Systematic Review and Indirect Comparison","volume":"12","author":"Newman","year":"2021","journal-title":"Front. Neurol."},{"key":"10.1016\/j.omtm.2021.09.013_bib11","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/WNO.0000000000001367","article-title":"Long-term follow-up after unilateral intravitreal gene therapy for Leber hereditary optic neuropathy: the RESTORE study","volume":"41","author":"Biousse","year":"2021","journal-title":"J.\u00a0Neuroophthalmol."},{"key":"10.1016\/j.omtm.2021.09.013_bib12","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ebiom.2016.07.002","article-title":"Long-term outcomes of gene therapy for the treatment of Leber\u2019s hereditary optic neuropathy","volume":"10","author":"Yang","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.omtm.2021.09.013_bib13","doi-asserted-by":"crossref","first-page":"21587","DOI":"10.1038\/srep21587","article-title":"Efficacy and Safety of rAAV2-ND4 Treatment for Leber\u2019s Hereditary Optic Neuropathy","volume":"6","author":"Wan","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtm.2021.09.013_bib14","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1159\/000487485","article-title":"Visual Field Variability after Gene Therapy for Leber\u2019s Hereditary Optic Neuropathy","volume":"60","author":"Yuan","year":"2018","journal-title":"Ophthalmic Res."},{"key":"10.1016\/j.omtm.2021.09.013_bib15","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.ophtha.2020.02.023","article-title":"Seven-Year Follow-up of Gene Therapy for Leber\u2019s Hereditary Optic Neuropathy","volume":"127","author":"Yuan","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.omtm.2021.09.013_bib16","doi-asserted-by":"crossref","first-page":"e730","DOI":"10.1111\/aos.14379","article-title":"Factors associated with rapid improvement in visual acuity in patients with Leber\u2019s hereditary optic neuropathy after gene therapy","volume":"98","author":"Liu","year":"2020","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.omtm.2021.09.013_bib17","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/WNO.0000000000001045","article-title":"Visual Outcomes in Leber Hereditary Optic Neuropathy Patients With the m.11778G>A (MTND4) Mitochondrial DNA Mutation","volume":"40","author":"Newman","year":"2020","journal-title":"J.\u00a0Neuroophthalmol."},{"key":"10.1016\/j.omtm.2021.09.013_bib18","doi-asserted-by":"crossref","unstructured":"Yu-Wai-Man, P., Newman, N.J., Carelli, V., La Morgia, C., Biousse, V., Bandello, F.M., Clermont, C.V., Campillo, L.C., Leruez, S., Moster, M.L., et\u00a0al.; LHON REALITY Study Group (2021). Natural history of patients with Leber hereditary optic neuropathy-results from the REALITY study. Eye (Lond.).","DOI":"10.1038\/s41433-021-01535-9"},{"key":"10.1016\/j.omtm.2021.09.013_bib19","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s40259-021-00468-9","article-title":"Safety of Intravitreal Gene Therapy for Treatment of Subjects with Leber Hereditary Optic Neuropathy due to Mutations in the Mitochondrial ND4 Gene: The REVEAL Study","volume":"35","author":"Vignal-Clermont","year":"2021","journal-title":"BioDrugs"},{"key":"10.1016\/j.omtm.2021.09.013_bib20","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.ophtha.2015.10.025","article-title":"Gene Therapy for Leber Hereditary Optic Neuropathy: Initial Results","volume":"123","author":"Feuer","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.omtm.2021.09.013_bib21","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/j.ophtha.2017.05.016","article-title":"Gene Therapy for Leber Hereditary Optic Neuropathy: Low- and Medium-Dose Visual Results","volume":"124","author":"Guy","year":"2017","journal-title":"Ophthalmology"},{"key":"10.1016\/j.omtm.2021.09.013_bib22","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(17)31868-8","article-title":"Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial","volume":"390","author":"Russell","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.omtm.2021.09.013_bib23","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1093\/brain\/awt343","article-title":"Efficient mitochondrial biogenesis drives incomplete penetrance in Leber\u2019s hereditary optic neuropathy","volume":"137","author":"Giordano","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.omtm.2021.09.013_bib24","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1089\/ars.2014.6200","article-title":"Regulation of mitochondrial biogenesis and its intersection with inflammatory responses","volume":"22","author":"Cherry","year":"2015","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.omtm.2021.09.013_bib25","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41593-017-0029-5","article-title":"Single-cell analysis of experience-dependent transcriptomic states in the mouse visual cortex","volume":"21","author":"Hrvatin","year":"2018","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.omtm.2021.09.013_bib26","first-page":"767","article-title":"Residual vision activation and the brain-eye-vascular triad: Dysregulation, plasticity and restoration in low vision and blindness - a review","volume":"36","author":"Sabel","year":"2018","journal-title":"Restor. Neurol. Neurosci."},{"key":"10.1016\/j.omtm.2021.09.013_bib27","doi-asserted-by":"crossref","first-page":"e1002569","DOI":"10.1371\/journal.pbio.1002569","article-title":"Visual BOLD Response in Late Blind Subjects with Argus II Retinal Prosthesis","volume":"14","author":"Castaldi","year":"2016","journal-title":"PLoS Biol."},{"key":"10.1016\/j.omtm.2021.09.013_bib28","doi-asserted-by":"crossref","first-page":"591","DOI":"10.47102\/annals-acadmedsg.V37N7p591","article-title":"Effects on the contralateral eye after intravitreal bevacizumab and ranibizumab injections: a case report","volume":"37","author":"Wu","year":"2008","journal-title":"Ann. Acad. Med. Singap."},{"key":"10.1016\/j.omtm.2021.09.013_bib29","first-page":"400","article-title":"Bilateral response following unilateral intravitreal bevacizumab injection in a child with uveitic cystoid macular edema","volume":"13","author":"Al-Dhibi","year":"2009","journal-title":"J.\u00a0AAPOS"},{"key":"10.1016\/j.omtm.2021.09.013_bib30","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/eye.2014.94","article-title":"Fellow eye effect of unilateral intravitreal bevacizumab injection in eyes with diabetic macular edema","volume":"28","author":"Hanhart","year":"2014","journal-title":"Eye (Lond.)"},{"key":"10.1016\/j.omtm.2021.09.013_bib31","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.neuron.2016.11.045","article-title":"AAV-Mediated Anterograde Transsynaptic Tagging: Mapping Corticocollicular Input-Defined Neural Pathways for Defense Behaviors","volume":"93","author":"Zingg","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.omtm.2021.09.013_bib32","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1167\/iovs.09-3740","article-title":"Combined application of BDNF to the eye and brain enhances ganglion cell survival and function in the cat after optic nerve injury","volume":"51","author":"Weber","year":"2010","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.omtm.2021.09.013_bib33","doi-asserted-by":"crossref","first-page":"18810","DOI":"10.1073\/pnas.2009425117","article-title":"Redistribution of metabolic resources through astrocyte networks mitigates neurodegenerative stress","volume":"117","author":"Cooper","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2021.09.013_bib34","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ceb.2016.02.022","article-title":"Mechanics of mitochondrial motility in neurons","volume":"38","author":"Barnhart","year":"2016","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.omtm.2021.09.013_bib35","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s40478-018-0542-0","article-title":"Astrocyte remodeling without gliosis precedes optic nerve Axonopathy","volume":"6","author":"Cooper","year":"2018","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.omtm.2021.09.013_bib36","doi-asserted-by":"crossref","first-page":"100953","DOI":"10.1016\/j.preteyeres.2021.100953","article-title":"Adaptive responses to neurodegenerative stress in glaucoma","volume":"84","author":"Calkins","year":"2021","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.omtm.2021.09.013_bib37","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1126\/science.1258295","article-title":"Neuroscience. Astrocytes eyeball axonal mitochondria","volume":"345","author":"Burdett","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.omtm.2021.09.013_bib38","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nature18928","article-title":"Transfer of mitochondria from astrocytes to neurons after stroke","volume":"535","author":"Hayakawa","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.omtm.2021.09.013_bib39","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.preteyeres.2003.10.003","article-title":"Mitochondrial dysfunction as a cause of optic neuropathies","volume":"23","author":"Carelli","year":"2004","journal-title":"Prog. Retin. Eye Res."}],"container-title":["Molecular Therapy - Methods & Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050121001510?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050121001510?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T09:26:52Z","timestamp":1762421212000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050121001510"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":39,"alternative-id":["S2329050121001510"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2021.09.013","relation":{},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biodistribution of intravitreal lenadogene nolparvovec gene therapy in nonhuman primates","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2021.09.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors.","name":"copyright","label":"Copyright"}]}}